Copyright © 2025 TKG VENTURES. All rights reserved.
A biotech company developing next-generation therapeutics based on its proprietary targeted protein degradation (TPD) platform, "AbRaptor"
Go to homepageDevelops and produces next-generation Dermal Fillers based on cell regeneration mechanisms
Go to homepageDevelopment of Therapeutic Agents for Vascular Diseases Related to Microvascular Abnormalities.
Go to homepageExoCoBio develops exosome-based biomedicine for regenerative aesthetics. They hit dramatic sales records with ASCE+ stimulation and have dominated technical product positioning.
Go to homepage